April 30, 2025
A recent study by Han et al.(2025) aims to predict which patients with myasthenia gravis might not respond well to standard treatments early in their diagnosis.The goal is to identify refractory cases within the first year, as current methods often take years to confirm treatment resistance.Early prediction could enable doctors to explore alternative therapies sooner, potentially improving outcomes.By focusing on timely intervention, this approach may lead to better disease management strategies and quality of life for refractory patients.The study highlights the need for early identification to optimize treatment plans and reduce delays in effective care (Han et al., 2025).
Melissa, who is a nurse and lives with MG, shares her perspective in this MGFA blog post:https://myasthenia.org/blog/2022/08/01/managing-mg-a-nurses-perspective/
🔍 Today is Undiagnosed DayEach year, thousands live with unexplained symptoms, searching for answers and validation. For some, like those eventually diagnosed with myasthenia gravis (MG), the path to diagnosis can be long and isolating.At the Myasthenia Gravis Association, we stand with the undiagnosed — listening, supporting, and advocating for earlier recognition and access to care. 💚If you're still searching for answers, you are not alone.📚 Learn more. Ask questions. Keep going.📩 Contact us: [email protected]🌐 Visit: www.mgakc.org
As suddenly as FB locked me out, they let me back - go figure.